Hansen B, Larsen P, Manthorpe R
Department of Internal Medicine, University of Lund, Malmö General Hospital, Sweden.
Allergy. 1988 Nov;43(8):577-85. doi: 10.1111/j.1398-9995.1988.tb00930.x.
SS-B/La antigen was purified by immunoadsorbent columns with immunoglobulin from a patient with primary Sjögren's syndrome. Monitoring of the purification was facilitated by the fused rocket-immunoelectrophoresis technique. Technical ELISA variables for the detection of serum antibodies against the SS-B/La antigen were evaluated, and a recommended procedure is described. Prospective investigation of anti-SS-B/La antibodies in 103 blood donors and 131 patients with chronic inflammatory connective tissue diseases, including 43 patients with primary Sjögren's syndrome was performed. Anti-SS-B/La antibody concentrations were above normal in 65% of the patients with primary Sjögren's syndrome (verified by the strictly objective Copenhagen criteria for keratoconjunctivitis sicca and xerostomia) and 9% of patients with other chronic connective tissue diseases. The predictive value for primary Sjögren's syndrome among patients with increased levels of the anti-SS-B/La antibodies attending a rheumatology clinic was 78%.
采用来自原发性干燥综合征患者的免疫球蛋白通过免疫吸附柱纯化SS - B/La抗原。融合火箭免疫电泳技术有助于监测纯化过程。评估了用于检测抗SS - B/La抗原血清抗体的技术ELISA变量,并描述了推荐的操作程序。对103名献血者和131名慢性炎症性结缔组织病患者进行了抗SS - B/La抗体的前瞻性研究,其中包括43名原发性干燥综合征患者。65%的原发性干燥综合征患者(根据用于干燥性角结膜炎和口干症的严格客观的哥本哈根标准确诊)和9%的其他慢性结缔组织病患者的抗SS - B/La抗体浓度高于正常水平。在风湿科门诊抗SS - B/La抗体水平升高的患者中,原发性干燥综合征的预测价值为78%。